DIVIDEND ANNOUNCEMENT: Pfd Conv Exchangeable 6%/Bio Green Med Solution Inc (OTCBB:BGMSP) on 08/12/2026 declared a dividend of $0.1500 per share

Pfd Conv Exchangeable 6%/Bio Green Med Solution Inc (OTCBB:BGMSP) on 08/12/2026 declared a dividend of $ 0.1500 per share payable on August 01, 2026 to shareholders of record as of July 23, 2026.

Pfd Conv Exchangeable 6%/Bio Green Med Solution Inc (OTCBB:BGMSP) has paid dividends since 2025, has a current dividend yield of 19.7368431091% and has increased its dividends for 0 successive years.

Pfd Conv Exchangeable 6%/Bio Green Med Solution Inc's market cap is $ 6,222,880 and has a PE ratio of 0.00. The stock price closed yesterday at $ 3.04 and has a 52 week low/high of $ 0.67 and $ 4.02.

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin-dependent kinase 9 (CDK9) inhibitor, in solid tumors and hematological malignancies. The epigenetic/anti-mitotic program is evaluating plogosertib, in solid tumors and hematological malignancies.

For more information on Pfd Conv Exchangeable 6%/Bio Green Med Solution Inc click here.